- Home
- PFLT vs SIBN Comparison
PFLT vs SIBN Comparison
Compare PFLT & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFLT
- SIBN
- Stock Information
- Founded
- PFLT 2010
- SIBN 2008
- Country
- PFLT United States
- SIBN United States
- Employees
- PFLT N/A
- SIBN N/A
- Industry
- PFLT Finance: Consumer Services
- SIBN Medical/Dental Instruments
- Sector
- PFLT Finance
- SIBN Health Care
- Exchange
- PFLT Nasdaq
- SIBN Nasdaq
- Market Cap
- PFLT 1.0B
- SIBN 805.4M
- IPO Year
- PFLT N/A
- SIBN 2018
- Fundamental
- Price
- PFLT $10.57
- SIBN $18.43
- Analyst Decision
- PFLT Buy
- SIBN Strong Buy
- Analyst Count
- PFLT 6
- SIBN 5
- Target Price
- PFLT $11.17
- SIBN $24.40
- AVG Volume (30 Days)
- PFLT 782.6K
- SIBN 487.7K
- Earning Date
- PFLT 08-11-2025
- SIBN 08-04-2025
- Dividend Yield
- PFLT 11.65%
- SIBN N/A
- EPS Growth
- PFLT N/A
- SIBN N/A
- EPS
- PFLT 0.86
- SIBN N/A
- Revenue
- PFLT $232,975,000.00
- SIBN $176,601,000.00
- Revenue This Year
- PFLT $45.52
- SIBN $19.48
- Revenue Next Year
- PFLT $8.87
- SIBN $16.86
- P/E Ratio
- PFLT $12.25
- SIBN N/A
- Revenue Growth
- PFLT 49.56
- SIBN 22.60
- 52 Week Low
- PFLT $8.82
- SIBN $11.70
- 52 Week High
- PFLT $12.02
- SIBN $20.05
- Technical
- Relative Strength Index (RSI)
- PFLT 61.46
- SIBN 53.78
- Support Level
- PFLT $10.44
- SIBN $17.80
- Resistance Level
- PFLT $10.59
- SIBN $18.58
- Average True Range (ATR)
- PFLT 0.14
- SIBN 0.59
- MACD
- PFLT 0.03
- SIBN 0.02
- Stochastic Oscillator
- PFLT 90.83
- SIBN 76.00
About PFLT PennantPark Floating Rate Capital Ltd.
PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generate revenue in the form of interest income on the debt securities and dividends.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.